IFNA1 and Hepatic fibrosis: However, liver fibrosis regression after SVR with peg-IFN-α/ribavirin is slow since some of the cured patients maintain a low rate of liver fibrosis progression [28, 29] and develop LREs [30–32], making monitoring of the cirrhotic patient necessary after the eradication of HCV.